Considering the fact that there are different ways to activate NF-kB pathway (IkB dependent and independent ways) [46] we decided to inhibit IKK activity rather than targeting IkappaBalpha itself to look for the possibility of sensitizing MCF7 breast cancer cells to TRAIL. This evidence concerns the gene NFKBIA and breast cancer.